Home
Medicines
COVID-19
Adverse event reporting
Active ingredients
Companies
Advanced search
Login
Search Medicine Database
Home
Medicines
COVID-19
More
expand_more
Login
menu
Home
Active ingredients
durvalumab
durvalumab
Medicine
Status
PIL
SPC
Legal Category
Active Ingredients
Company
IMFINZI 50 mg/mL concentrate for solution for infusion
Updated
PIL
14/07/21
SPC
14/07/21
A
durvalumab
AstraZeneca Pharmaceuticals (Ireland) DAC
Documents associated with this medicine were updated in the last 30 days.
Date of Update on Medicines.ie
Product subject to medical prescription which may not be renewed (A)
